Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Risk factors for superficial vein thrombosis in patients with primary chronic venous disease

D. Musil, M. Kaletova, J. Herman,

. 2016 ; 45 (1) : 63-6.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc16019992

BACKGROUND: Primary chronic venous disease (CVD) is associated with an increased risk of superficial vein thrombosis (SVT). While CVD is a predominant factor in SVT, there is a range of additional predisposing factors. The objective was to investigate the association between age, gender, BMI, smoking, oestrogen hormone therapy, family history of venous thromboembolism (VTE) and CEAP clinical classification in patients with CVD and a history of SVT. PATIENTS AND METHODS: In a retrospective observational study on consecutive patients with primary CVD, 641 outpatients were enrolled (152 men, 23.7%; 489 women, 76.3%). The prevalence of SVT was evaluated according to age, BMI, smoking, presence of family history of VTE, use of hormone therapy, and clinical class of CVD. RESULTS: Risk of SVT was significantly increased in women (OR 1.68, 95% CI = 1.02-2.76; p = 0.041), older patients (46-69 years, OR 1.57, 95% CI = 1.03-2.4; p = 0.036, ≥ 70 years, OR 2.93, 95% CI = 1.5-5.76; p = 0.001), smokers (OR 1.69, 95% CI = 1.1-2.58; p = 0.015) and in persons with first-degree siblings diagnosed with VTE (OR 2,28, 95% CI = 1.28-4.05; p = 0.004). The risk was significantly increased in older male smokers (p - 0.042). In women, smoking and oestrogen therapy (p = 0.495) did not increase the risk of SVT even older women or in those with increased BMI. In CVD (C0-C3), a history of episodes of SVT was found in 103/550 (18.7%), in chronic venous insufficiency (CVI) in 27/91 (29.7%). There was a significantly higher prevalence of SVT in patients with CVI (OR 1.70, 95% CI = 1.1-2.5; p = 0.016). CONCLUSIONS: In patients with primary CVD, SVT was significantly associated with female gender. In men, older age, smoking and positive family history of VTE were relevant SVT risk factors. In women, risk factors were older age, BMI ≥ 25 kg/m2 and positive family history of VTE. Compared with C0-C3 clinical classes, CVI significantly increases the risk of SVT.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16019992
003      
CZ-PrNML
005      
20160801114831.0
007      
ta
008      
160722s2016 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1024/0301-1526/a000497 $2 doi
024    7_
$a 10.1024/0301-1526/a000497 $2 doi
035    __
$a (PubMed)26986712
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Musil, Dalibor $u 1 Department of Internal Medicine I, Cardiology, Teaching Hospital, Olomouc, Czech Republic.
245    10
$a Risk factors for superficial vein thrombosis in patients with primary chronic venous disease / $c D. Musil, M. Kaletova, J. Herman,
520    9_
$a BACKGROUND: Primary chronic venous disease (CVD) is associated with an increased risk of superficial vein thrombosis (SVT). While CVD is a predominant factor in SVT, there is a range of additional predisposing factors. The objective was to investigate the association between age, gender, BMI, smoking, oestrogen hormone therapy, family history of venous thromboembolism (VTE) and CEAP clinical classification in patients with CVD and a history of SVT. PATIENTS AND METHODS: In a retrospective observational study on consecutive patients with primary CVD, 641 outpatients were enrolled (152 men, 23.7%; 489 women, 76.3%). The prevalence of SVT was evaluated according to age, BMI, smoking, presence of family history of VTE, use of hormone therapy, and clinical class of CVD. RESULTS: Risk of SVT was significantly increased in women (OR 1.68, 95% CI = 1.02-2.76; p = 0.041), older patients (46-69 years, OR 1.57, 95% CI = 1.03-2.4; p = 0.036, ≥ 70 years, OR 2.93, 95% CI = 1.5-5.76; p = 0.001), smokers (OR 1.69, 95% CI = 1.1-2.58; p = 0.015) and in persons with first-degree siblings diagnosed with VTE (OR 2,28, 95% CI = 1.28-4.05; p = 0.004). The risk was significantly increased in older male smokers (p - 0.042). In women, smoking and oestrogen therapy (p = 0.495) did not increase the risk of SVT even older women or in those with increased BMI. In CVD (C0-C3), a history of episodes of SVT was found in 103/550 (18.7%), in chronic venous insufficiency (CVI) in 27/91 (29.7%). There was a significantly higher prevalence of SVT in patients with CVI (OR 1.70, 95% CI = 1.1-2.5; p = 0.016). CONCLUSIONS: In patients with primary CVD, SVT was significantly associated with female gender. In men, older age, smoking and positive family history of VTE were relevant SVT risk factors. In women, risk factors were older age, BMI ≥ 25 kg/m2 and positive family history of VTE. Compared with C0-C3 clinical classes, CVI significantly increases the risk of SVT.
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a rozdělení chí kvadrát $7 D016009
650    _2
$a chronická nemoc $7 D002908
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a logistické modely $7 D016015
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a odds ratio $7 D016017
650    _2
$a rodokmen $7 D010375
650    _2
$a prevalence $7 D015995
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a sexuální faktory $7 D012737
650    _2
$a kouření $x škodlivé účinky $x epidemiologie $7 D012907
650    _2
$a žilní insuficience $x diagnóza $x epidemiologie $7 D014689
650    _2
$a žilní trombóza $x diagnóza $x epidemiologie $x genetika $7 D020246
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Kaletova, Marketa $u 1 Department of Internal Medicine I, Cardiology, Teaching Hospital, Olomouc, Czech Republic.
700    1_
$a Herman, Jiri $u 2 Department of Surgery II - Vascular and Transplantation Surgery, Teaching Hospital, Olomouc, Czech Republic.
773    0_
$w MED00004632 $t VASA. Zeitschrift für Gefässkrankheiten $x 0301-1526 $g Roč. 45, č. 1 (2016), s. 63-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26986712 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160801115059 $b ABA008
999    __
$a ok $b bmc $g 1154662 $s 944520
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 45 $c 1 $d 63-6 $i 0301-1526 $m VASA $n VASA $x MED00004632
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...